JiangTang XiaoKe granule attenuates cathepsin K expression and improves IGF-1 expression in the bone of high fat diet induced KK-Ay diabetic mice

• DOI: 10.1016/j.lfs.2016.02.056
• Publication Date: 2016-02-15T15:08:44Z
• Authors: Yubo Guo; Lili Wang; Rufeng Ma; Qianqian Mu; Na Yu; Yi Zhang; Yuqing Tang; Yu Li; Guangjian Jiang; Dandan Zhao; Fangfang Mo; Sihua Gao; Meijuan Yang; Feifei Kan; Qun Ma; Min Fu; Dongwei Zhang
• Keywords: Male; 0303 health sciences; Cathepsin K; Diet, High-Fat; Diabetes Mellitus, Experimental; Mice, Inbred C57BL; Mice; 03 medical and health sciences; Gene Expression Regulation; Bone Density; Animals; Insulin-Like Growth Factor I; Drugs, Chinese Herbal

To assess the beneficial effects of JiangTang XiaoKe (JTXK) granule on the bone metabolism in high fat diet (HFD) fed KK-Ay diabetic mice.The KK-Ay mice were used as a diabetic model, while C57BL/6 mice were utilized as the non-diabetic control. The left tibia was used for determining bone mineral density (BMD) and bone ash coefficient. The HE and alizarin red S staining of femur were employed to evaluate bone pathology and calcium deposition. The expressions of alkaline phosphatase (ALP), insulin growth factor 1 (IGF-1) and cathepsin K were assessed by western blotting and immunohistochemical staining.JTXK granule significantly improved the bone ash coefficient, the distribution of trabecular bone and the calcification nodules deposition in KK-Ay mice with diabetes. IGF-1 and ALP expressions were significantly decreased, and cathepsin K expression was dramatically increased in the HFD fed KK-Ay diabetic model mice, which can be reversed by JTXK granule treatment. JTXK granule at medium or high dosage was more efficient in improving diabetic bone quality when compared with that in mice with a low dosage. However, the BMD values in each group of KK-Ay diabetic mice were not significantly different.We demonstrate that cathepsin K expression is increased in KK-Ay diabetic mouse model. JTXK granule treatment inhibits osteoclastic bone resorption and promotes the new bone formation by decreasing cathepsin K activity and increasing IGF-1 and ALP levels. These changes may contribute to the increase of bone strength and thus reducing the risk of bone fractures.